NCCN Clinical Practice Guidelines Occult primary

J Natl Compr Canc Netw. 2011 Dec;9(12):1358-95. doi: 10.6004/jnccn.2011.0117.

Abstract

Occult primary tumors, or cancers of unknown primary (CUPs), are defined as histologically proven metastatic malignant tumors whose primary site cannot be identified during pretreatment evaluation. They have a wide variety of clinical presentations and a poor prognosis in most patients. Patients with occult primary tumors often present with general complaints, such as anorexia and weight loss. Clinical absence of primary tumor, early dissemination, aggressiveness, and unpredictability of metastatic pattern are characteristic of these tumors. Life expectancy is very short, with a median survival of 6 to 9 months. In most patients, occult primary tumors are refractory to systemic treatments, and chemotherapy is only palliative and does not significantly improve long-term survival. However, certain clinical presentations of these tumors are associated with a better prognosis. Special pathologic studies can identify subsets of patients with tumor types that are more responsive to chemotherapy. Treatment options should be individualized for this selected group of patients to achieve improved response and survival rates.

Publication types

  • Practice Guideline

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / epidemiology
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Algorithms
  • Antibodies / analysis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma / diagnosis
  • Carcinoma / epidemiology
  • Carcinoma / pathology
  • Carcinoma / therapy
  • Female
  • Humans
  • Lymphatic Metastasis
  • Male
  • Medical Oncology / legislation & jurisprudence*
  • Medical Oncology / organization & administration
  • Molecular Diagnostic Techniques / methods
  • Neoplasms, Unknown Primary / diagnosis
  • Neoplasms, Unknown Primary / epidemiology
  • Neoplasms, Unknown Primary / therapy*
  • Practice Guidelines as Topic*
  • Societies, Medical / legislation & jurisprudence
  • Societies, Medical / organization & administration
  • United States

Substances

  • Antibodies